Friday, 18 Oct 2019

PsA/SpA

Date Typesort ascending Title Save
17 Feb 2017 Social RT @DrRachelTate: Tofa as an option for AS? No FDA indication but a potential off label option. E. Ruderman MD #rwcs2017 @RWCSmtg @RheumNow…
15 Sep 2016 Social RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #…
07 Nov 2017 Social RT @Lupusdoc: Poster title of the day....! #2556 @RheumNow #ACR17 https://t.co/nDmsAQQS19
14 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST thu0297 CVRF higher in PSO, PsA & periph SpA w/o PSO comparing to gen pop but similar amongst the Dx…
16 Oct 2017 Social Population survey found psoriasis/PsA in 1.4-3.3%; Nearly 1/2 not seeing MD or stopped biologic for safety/no effect https://t.co/JGHWuIUacK
28 Mar 2017 Social RT @CBSHealth: FDA approves powerful new drug for eczema -- but it comes with a hefty price tag https://t.co/EOjOgCdoci https://t.co/V49wgh…
17 Apr 2019 Social Comparing fibromyalgia, PsA, Psoriasis Pts - FM has more entheseal tenderness (92%) than PSA (66%) and PSO (59%). However with ultrasound, entheseal involvement were more frequent in PsA & psoriasis (~90%) vs FM (75%). What? US enthesitis in FM? https://t.co/wNBQEB3j0O
23 Oct 2016 Social Dr. Sergio Schwartzman comments on new Ocular Screening Guidlines for Hydroxychloroquine at RheumNow https://t.co/Qm1iDM77Jo
08 Jun 2016 Social Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow https://t.co/zjA8Rgw0cX
08 Nov 2017 Social RT @_connectedcare: Lots of different causes for Red Eye in autoimmune arthritis. Here’s a list #ACR17 @RheumNow https://t.co/pMi2tLMDpk
13 Jan 2019 Social QD Video on RheumNow - an HLA-B27+ patient with Iritis, Enthesitis, Diarrhea. https://t.co/LusZttdAyw
04 Nov 2017 Social RT @DrPetryna: GI mucosal associated invariant T (MAIT) cells detected in joints of patients w/AS. Expanding views of SpA #ACR17 Sunday pre…
17 Jun 2019 Social RT @tuna0sashimi: FUTURE 5 secukinumab in PsA placebo arm only 12w. Week 52 pt can increase doses from 150mg to 300mg. 2y data presented. S…
04 Jan 2017 Social NICE recommends apremilast for use in psoriatic arthritis w/in UK NHS. Risk of suidical ideation is 0.2% (3/1441) https://t.co/ZFDSo3B81u
11 Nov 2015 Social Dr Atul Deodhar on video at RheumNow, discussing new therapies for ankylosing splondylitis. Live from #ACR15 https://t.co/wJFcAurQYE
05 Nov 2017 Social RT @doctorakerkar: Therapies to look forward to in #AnkylosingSpondylitis #ACR17 https://t.co/h9uZQ08wbD
18 Jul 2017 Social 320 pt Rheum-Derm clinic in Vancouver - lupus is most common rheum dx; dermatitis & psoriasis most common Derm Dx https://t.co/soA3UXsfXF
29 Dec 2017 Social Causes of Dactylitis = PsA, AS, SpA, reactive arthritis, MCTD, PSS, TB, syphilis, JIA, Sarcoid https://t.co/nhotKuYF2n
14 Oct 2018 Social RheumNow Wk in Review is up! Info on SSc-SSLE overlap, capillaroscopy fingers, Women with SpA, acute gout management and lupus patients in pain in the ED. Watch here https://t.co/wB10SaVXF7 Or checkout the podcasts at iTunes or here https://t.co/5GdSlCyWmW
02 Jul 2015 Social Ixekizumab (anti-IL17) is superior to Enbrel in 1224 pts w/ plaque psoriasis (UNCOVER-2) w/ rapid decr in itch scores http://t.co/ozZbHEq6Wu